Sign Up to like & get
recommendations!
0
Published in 2020 at "Frontiers in Molecular Biosciences"
DOI: 10.3389/fmolb.2020.598998
Abstract: Despite class A ESBLs carrying substitutions outside catalytic regions, such as Cys69Tyr or Asn136Asp, have emerged as new clinical threats, the molecular mechanisms underlying their acquired antibiotics-hydrolytic activity remains unclear. We discovered that this non-catalytic-region…
read more here.
Keywords:
esbls;
region mutations;
non catalytic;
class ... See more keywords